SIBN Stock Summary and Trading Ideas (Si-Bone | NASDAQ:SIBN)

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Si-Bone trades on the NASDAQ stock market under the symbol SIBN.

As of September 24, 2026, SIBN stock price declined to $18.52 with 610,453 million shares trading.

SIBN has a beta of 0.33, meaning it tends to be less sensitive to market movements. SIBN has a correlation of 0.01 to the broad based SPY ETF.

SIBN has a market cap of $821.35 million. This is considered a Small Cap stock.

Last quarter Si-Bone reported $56 million in Revenue and -$.09 earnings per share. This beat revenue expectation by $761,272 and exceeded earnings estimates by $.06.

In the last 3 years, SIBN traded as high as $22.56 and as low as $11.48.

The top ETF exchange traded funds that SIBN belongs to (by Net Assets): VTI, VXF, VTWO, SCHA, DFAS.

SIBN has outperformed the market in the last year with a return of +30.2%, while the SPY ETF gained +17.2%. In the last 3 month period, SIBN beat the market returning +13.3%, while SPY returned +4.9%. However, in the most recent 2 weeks SIBN has underperformed the stock market by returning +1.2%, while SPY returned +1.5%.

SIBN support price is $18.14 and resistance is $19.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SIBN shares will trade within this expected range on the day.